Christopher L. Corless
Impact in
- Gastroenterology top 0.01%
- Gastrointestinal Tumor Research and Treatment
- Pulmonary and Respiratory Medicine top 0.02%
- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Renal cell carcinoma treatment
Papers in
-
- Sarcoma Diagnosis and Treatment 60
- Gastric Cancer Management and Outcomes 22
- Renal cell carcinoma treatment 13
- Gastroenterology 100
- Gastrointestinal Tumor Research and Treatment 99
- Co-authors
- Michael C. Heinrich (107 shared papers)Jonathan A. Fletcher (29 shared papers)Christopher D.�M. Fletcher (19 shared papers)Brian P. Rubin (20 shared papers)George D. Demetri (23 shared papers)Charles D. Blanke (23 shared papers)Ajia Town (10 shared papers)Laura McGreevey (7 shared papers)
- Journals
- Journal of Clinical Oncology (46 papers)The American Journal of Surgical Pathology (18 papers)Clinical Cancer Research (12 papers)Cancer Research (11 papers)The American Journal of Surgery (10 papers)
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Christopher L. Corless
320 papers receiving 31.5k citations
Christopher L. Corless's Hit Papers
Peers
Comparison fields: 5 of 146
- Gastroenterology 15.3k
- Pulmonary and Respiratory Medicine 12.9k
- Neurology 3.0k
- Oncology 5.3k
- Cancer Research 2.7k
Countries citing papers authored by Christopher L. Corless
This map shows the geographic impact of Christopher L. Corless's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Corless with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Corless more than expected).
Fields of papers citing papers by Christopher L. Corless
This network shows the impact of papers produced by Christopher L. Corless. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Corless. The network helps show where Christopher L. Corless may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher L. Corless, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 326 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diagnosis of gastrointestinal stromal tumors: A consensus approach Hit paper breakdown → | 2002 | 2634 |
| 2 | PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors Hit paper breakdown → | 2003 | 1858 |
| 3 | Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor Hit paper breakdown → | 2003 | 1840 |
| 4 | Biology of Gastrointestinal Stromal Tumors Hit paper breakdown → | 2004 | 950 |
| 5 | Gastrointestinal stromal tumour Hit paper breakdown → | 2007 | 842 |
| 6 | Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KIT Hit paper breakdown → | 2008 | 795 |
| 7 | PDGFRA Mutations in Gastrointestinal Stromal Tumors: Frequency, Spectrum and In Vitro Sensitivity to Imatinib Hit paper breakdown → | 2005 | 665 |
| 8 | Gastrointestinal stromal tumours: origin and molecular oncology Hit paper breakdown → | 2011 | 646 |
| 9 | Molecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors Hit paper breakdown → | 2006 | 640 |
| 10 | Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor Hit paper breakdown → | 2008 | 591 |
| 11 | KIT Gene Mutations and Copy Number in Melanoma Subtypes Hit paper breakdown → | 2008 | 527 |
| 12 | Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205 Hit paper breakdown → | 2010 | 518 |
| 13 | The Novel Marker, DOG1, Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation Status Hit paper breakdown → | 2004 | 515 |
| 14 | Gastrointestinal stromal tumour Hit paper breakdown → | 2013 | 484 |
| 15 | Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels Hit paper breakdown → | 2017 | 481 |
| 16 | Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group Hit paper breakdown → | 2008 | 461 |
| 17 | 2006 | 402 | |
| 18 | 2002 | 394 | |
| 19 | 2004 | 394 | |
| 20 | 2002 | 379 |
About Christopher L. Corless
Christopher L. Corless is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology, Surgery, Molecular Biology and Oncology, having authored 326 papers that have together received 32.9k indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (99 papers), Sarcoma Diagnosis and Treatment (60 papers), Cancer Genomics and Diagnostics (31 papers), Gastrointestinal disorders and treatments (30 papers), Gastric Cancer Management and Outcomes (22 papers), Neurofibromatosis and Schwannoma Cases (17 papers), Soft tissue tumor case studies (16 papers) and Renal cell carcinoma treatment (13 papers). The work is most often cited by research in Gastroenterology (15.3k citations), Pulmonary and Respiratory Medicine (12.9k citations), Neurology (3.0k citations), Oncology (5.3k citations) and Cancer Research (2.7k citations). Christopher L. Corless has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Michael C. Heinrich, Jonathan A. Fletcher, Christopher D.�M. Fletcher, Brian P. Rubin, George D. Demetri, Charles D. Blanke, Ajia Town, Laura McGreevey, Heikki Joensuu and Margaret von Mehren. Their work appears in journals such as Journal of Clinical Oncology, The American Journal of Surgical Pathology, Clinical Cancer Research, Cancer Research and The American Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.